Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 | original

read original more articles

Gilead said the deal would bolster its growing inflammation portfolio.

Explore topics: gilead sciences ouro medicines inflammation billion acquisition